journal article·2017-08

Bivalent cationic ions doped bioactive glasses: the influence of magnesium, zinc, strontium and copper on the physical and biological properties

Ilaria Cacciotti

Journal of Materials Science· Volume 52· Issue 15
Publisher page

Abstract

Bioactive glass and glass ceramic materials are widely used as substitutes for bone augmentation and restoration, in orthopaedic, dental and maxillofacial surgery and in the tissue engineering field. Indeed, these materials are bioactive, biocompatible, mechanically stable, biodegradable and favour osteointegration, being able to promote bone tissue formation at their surface and to bond to surrounding living tissues when implanted in the human body. It has been demonstrated that bioglass (BG) ionic dissolution products (e.g. Si, Ca, P and Na) are able to induce and stimulate the expressions of genes related to the osteoblastic differentiation and bone formation, to stimulate angiogenesis in vitro and in vivo, as well as to play possible antibacterial and anti-inflammatory actions. Thus, it is possible to tailor BGs properties properly formulating their chemical composition and adding selected ions with specific functional and biological role. In this perspective, Hench proposed a new generation of genetically designed glasses, on the basis of their ability to activate specific genes involved in in situ tissue regeneration, by doping silicate and phosphate glasses with several active ions, particularly metallic ions with therapeutic effects. In this framework, the present review is aimed to provide an overview about the effect of selected cationic substitutions (i.e. magnesium, zinc, strontium and copper), incorporated within the bioglasses structure, on the physical and biological properties of these materials, since the comprehension of the influence of the most employed metallic ions has to be considered pivotal to address the formulation of more promising and performing glasses.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Facial Trauma and Fracture Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Dorozhkin SV (2010) Bioceramics of calcium orthophosphates. Biomaterials 31:1465–148510.1016/j.biomaterials.2009.11.050 ↗
2. Bianco A, Cacciotti I, Lombardi M, Montanaro L, Gusmano G (2007) Thermal stability and sintering behaviour of hydroxyapatite nanopowders. J Thermal Anal Calor. 88:237–24310.1007/s10973-006-8011-6 ↗
3. Cacciotti I, Bianco A (2011) High thermally stable Mg-substituted tricalcium phosphate by precipitation. Ceram Inter 37:127–13710.1016/j.ceramint.2010.08.023 ↗
4. Hench LL (1998) Bioceramics. J Am Ceram Soc 81:1705–172810.1111/j.1151-2916.1998.tb02540.x ↗
5. Hench LL (1991) Bioceramics: from concept to clinic. J Am Ceram Soc 74(7):1487–151010.1111/j.1151-2916.1991.tb07132.x ↗
6. Cacciotti I, Lombardi M, Bianco A, Ravaglioli A, Montanaro L (2012) Sol-gel derived 45S5 bioglass: synthesis, microstructural evolution and thermal behaviour. J Mater Sci Mater Med 23(8):1849–186610.1007/s10856-012-4667-6 ↗
7. Hench LL, Xynos ID, Polak JM (2004) Bioactive glasses for in situ tissue regeneration. J Biomater Sci Polym Ed 15:543–56210.1163/156856204323005352 ↗
8. Day RM (2005) Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng 11:768–77710.1089/ten.2005.11.768 ↗
9. Hench LL (1993) Bioceramics. J Am Ceram Soc 81:1705–172810.1111/j.1151-2916.1998.tb02540.x ↗
10. Bueno EM, Glowacki J (2009) Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol 5(12):685–69710.1038/nrrheum.2009.228 ↗
11. Jell G, Stevens MM (2006) Gene activation by bioactive glasses. J Mater Sci Mater Med 17:997–100210.1007/s10856-006-0435-9 ↗
12. Cacciotti I. Cationic and Anionic substitutions in hydroxyapatite, In: Handbook of Bioceramics and Biocomposites, Iulian Vasile Antoniac Editor, Springer International Publishing 2016:145–21110.1007/978-3-319-12460-5_7 ↗
13. Saltman PD, Strause LG (1993) The role of trace minerals in osteoporosis. J Am Coll Nutr 12:384–38910.1080/07315724.1993.10718327 ↗
14. Cacciotti I, Bianco A, Lombardi M, Montanaro L (2009) Mg-substituted hydroxyapatite nanopowders: synthesis, thermal stability and sinterability. J Europ Ceram Soc 29(14):2969–297810.1016/j.jeurceramsoc.2009.04.038 ↗
15. Bianco A, Cacciotti I, Lombardi M, Montanaro L (2009) Si-substituted hydroxyapatite nanopowders: synthesis, thermal stability and sinterability. Mater Res Bull 44:345–35410.1016/j.materresbull.2008.05.013 ↗
16. Bianco A, Cacciotti I, Lombardi M, Montanaro L, Bemporad E, Sebastiani M (2010) F-substituted hydroxyapatite nanopowders: thermal stability, sintering behavior and mechanical properties. Ceram Inter 36(1):313–32210.1016/j.ceramint.2009.09.007 ↗
17. Hench LL (2009) Genetic design of bioactive glass. J Eur Ceram Soc 29:1257–126510.1016/j.jeurceramsoc.2008.08.002 ↗
18. Hoppe A, Güldal NS, Boccaccini AR (2011) A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 32:2757–277410.1016/j.biomaterials.2011.01.004 ↗
19. Mourino V, Cattalini JP, Boccaccini AR (2012) Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments. J R Soc Interface 9:401–41910.1098/rsif.2011.0611 ↗
20. Hoppe A, Mouriño V, Boccaccini AR (2013) Therapeutic inorganic ions in bioactive glasses to enhance bone formation and beyond. Biomater Sci 1:254–25610.1039/C2BM00116K ↗
21. Abou Neel EA, Chrzanowski W, Pickup DM, O’Dell LA, Mordan NJ, Newport RJ, Smith ME, Knowles JC (2009) Structure and properties of strontium-doped phosphate-based glasses. J R Soc Interface 6:435–44610.1098/rsif.2008.0348 ↗
22. Miola M, Vitale Brovarone C, Maina G, Rossi F, Bergandi L, Ghigo D, Saracino S, Maggiora M, Canuto RA, Muzio G et al (2014) In vitro study of manganese-doped bioactive glasses for bone regeneration. Mater Sci Eng C 38:107–11810.1016/j.msec.2014.01.045 ↗
23. Gomez-Vega J, Saiz E, Tomsia A, Marshall G, Marshall S (2000) Bioactive glass coatings with hydroxyapatite and Bioglass particles on Ti-based implants. 1. Processing. Biomaterials 21:105–11110.1016/S0142-9612(99)00131-3 ↗
24. Rau JV, Teghil R, Fosca M, De Bonis A, Cacciotti I, Bianco A, Caminiti R, Rossi Albertini V, Ravaglioli A (2012) Bioactive glass-ceramic coatings deposited by pulsed laser deposition from RKKP targets (sol-gel vs melt-processing route). Mater Res Bull 47:1130–113710.1016/j.materresbull.2012.02.011 ↗
25. Ledda M, De Bonis A, Bertani FR, Cacciotti I, Teghil R, Lolli MG, Ravaglioli A, Lisi A, Rau JV (2015) Interdisciplinary Approach to Cell-Biomaterial Interactions: biocompatibility and Cell Friendly Characteristics of RKKP Glass-Ceramic Coatings on Titanium. Biomed Material 10(3):03500510.1088/1748-6041/10/3/035005 ↗
26. De Bonis A, Curcio M, Fosca M, Cacciotti I, Santagata A, Teghil R (2016) Rau JV RBP1 bioactive glass-ceramic films obtained by pulsed laser deposition. Mater Lett 175:195–19810.1016/j.matlet.2016.04.044 ↗
27. Gerhardt LC, Widdows KL, Erol MM, Burch CW, Sanz-Herrera JA, Ochoa I, Stämpfli R, Roqan IS, Gabe S, Ansari T et al (2011) The pro-angiogenic properties of multi-functional bioactive glass composite scaffolds. Biomaterials 32:4096–410810.1016/j.biomaterials.2011.02.032 ↗
28. Rahaman MN, Day DE, Sonny Bal B, Fu Q, Jung SB, Bonewald LF et al (2011) Bioactive glass in tissue engineering. Acta Biomater 7:2355–237310.1016/j.actbio.2011.03.016 ↗
29. Jones JR (2013) Review of bioactive glass: from Hench to hybrids. Acta Biomater 9:4457–448610.1016/j.actbio.2012.08.023 ↗
30. Beattie JH, Avenell A (1992) Trace element nutrition and bone metabolism. Nutr Res Rev 5:167–18810.1079/NRR19920013 ↗
31. Nielsen F (1990) New essential trace elements for the life sciences. Biol Trace Elem Res 26–27:599–61110.1007/BF02992716 ↗
32. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM (2001) Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass_ 45S5 dissolution. J Biomed Mater Res 55:151–15710.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D ↗
33. Gorustovich AA, Roether JA, Boccaccini AR (2010) Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B Rev 16:199–20710.1089/ten.teb.2009.0416 ↗
34. Leu A, Leach J (2008) Proangiogenic potential of a collagen/bioactive glass substrate. Pharm Res 25:1222–122910.1007/s11095-007-9508-9 ↗
35. Allan I, Newman H, Wilson M (2001) Antibacterial activity of particulate Bioglass_against supra- and subgingival bacteria. Biomaterials 2001(22):1683–168710.1016/S0142-9612(00)00330-6 ↗
36. Gorriti MF, López JMP, Boccaccini AR, Audisio C, Gorustovich AA (2009) In vitro study of the antibacterial activity of bioactive glass-ceramic scaffolds. Adv Eng Mater 11:B67–B7010.1002/adem.200900081 ↗
37. Zhang D, Lepparanta O, Munukka E, Ylanen H, Viljanen MK, Eerola E, Hupa M, Hupa L (2010) Antibacterial effects and dissolution behavior of six bioactive glasses. J Biomed Mater Res A 93:475–48310.1002/jbm.a.32564 ↗
38. Stoor P, Söderling E, Salonen JI (1998) Antibacterial effects of a bioactive glass paste on oral microorganisms. Acta Odontol Scand 56:161–16510.1080/000163598422901 ↗
39. Leppäranta O, Vaahtio M, Peltola T, Zhang D, Hupa L, Hupa M et al (2008) Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci Mater Med 19:547–55110.1007/s10856-007-3018-5 ↗
40. Hu S, Chang J, Liu M, Ning C (2009) Study on antibacterial effect of 45S5 Bioglass. J Mater Sci Mater Med 20(1):281–28610.1007/s10856-008-3564-5 ↗
41. Jones J, Ehrenfried L, Saravanapavan P, Hench L (2006) Controlling ion release from bioactive glass foam scaffolds with antibacterial properties. J Mater Sci Mate Med 17:989–99610.1007/s10856-006-0434-x ↗
42. Yli-Urpo H, Närhi T, Söderling E (2003) Antimicrobial effects of glass ionomer cements containing bioactive glass (S53P4) on oral micro-organisms in vitro. Acta Odontol Scand 61:241–24610.1080/00016350310004719 ↗
43. Munukka E, Leppäranta O, Korkeamäki M, Vaahtio M, Peltola T, Zhang D et al (2008) Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med 19:27–3210.1007/s10856-007-3143-1 ↗
44. Day RM, Boccaccini AR (2005) Effect of particulate bioactive glasses on human macrophages and monocytes in vitro. J Biomed Mater Res A 73A:73–7910.1002/jbm.a.30262 ↗
45. Miguez-Pacheco V, Hench LL, Boccaccini AR (2015) Bioactive glasses beyond bone and teeth: emerging applications in contact with soft tissues. Acta Biomater 13:1–1510.1016/j.actbio.2014.11.004 ↗
46. Baino F, Novajra G, Miguez-Pacheco V, Boccaccini AR, Vitale-Brovarone C (2016) Bioactive glasses: special applications outside the skeletal system. J Non-Cryst Solids 432:15–3010.1016/j.jnoncrysol.2015.02.015 ↗
47. Miguez-Pacheco V, Greenspan D, Hench LL, Boccaccini AR (2015) Bioactive glasses in soft tissue repair. Am Ceram Soc Bull 94:27–31
48. Rath SN, Brandl A, Hiller D, Hoppe A, Gbureck U, Horch RE et al (2014) Bioactive copper-doped glass scaffolds can stimulate endothelial cells in co-culture in combination with mesenchymal stem cells. PLoS ONE 99(12):e11331910.1371/journal.pone.0113319 ↗
49. Kingery WD, Bowen HK, Uhlmann DR (1976) Introduction to Ceramics, 2nd edn. Wiley, New York
50. Shelby JE (2005) Introduction to Glass Science and Technology, 2nd edn. The Royal Society of Chemistry, Cambridge10.1039/9781847551160 ↗
51. Kaur G, Pandey OP, Singh K, Homa D, Scott B, Pickrell G (2014) A review of bioactive glasses: their structure, properties, fabrication, and apatite formation. J Biomed Mater Res A. 102(1):254–27410.1002/jbm.a.34690 ↗
52. Tilocca A (2009) Structural models of bioactive glasses from molecular dynamics simulations. Proc R Soc A 465:1003–102710.1098/rspa.2008.0462 ↗
53. Wers E, Oudadesse H (2014) Thermal behaviour and excess entropy of bioactive glasses and Zn-doped glasses. J Therm Anal Calorim 115(3):2137–214410.1007/s10973-013-3280-3 ↗
54. Cortizo AM, Molinuevo MS, Barrio DA, Bruzzone L (2006) Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanism of action. Int J Biochem Cell Biol 38(7):1171–118010.1016/j.biocel.2005.12.007 ↗
55. Marie PJ, Ammann P, Boivin G, Rey C (2001) Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69(3):121–12910.1007/s002230010055 ↗
56. Yamaguchi M (1998) Role of zinc in bone formation and bone resorption. J Trace Elem Exp Med 11(2–3):119–13510.1002/(SICI)1520-670X(1998)11:2/3<119::AID-JTRA5>3.0.CO;2-3 ↗
57. Sun ZL, Wataha JC, Hanks CT (1997) Effects of metal ions on osteoblast-like cell metabolism and differentiation. J Biomed Mater Res 34(1):29–3710.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P ↗
58. LeGeros RZ (1991) Calcium phosphates in oral biology and medicine. Karger, Basel
59. Zreiqat H, Howlett CR, Zannettino A, Evans P, Schulze-Tanzil G, Knabe C et al (2002) Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res 62(2):175–18410.1002/jbm.10270 ↗
60. Yamasaki Y, Yoshida Y, Okazaki M, Shimazu A, Uchida T, Kubo T et al (2002) Synthesis of functionally graded MgCO3 apatite accelerating osteoblast adhesion. J Biomed Mater Res 62(1):99–10510.1002/jbm.10220 ↗
61. Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Kilburn J (2005) Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat. Bone 37(2):211–21910.1016/j.bone.2005.04.005 ↗
62. Percival M (1999) Bone health and Osteoporosis. Appl Nutr Sci Rep 5(4):1–5
63. Bigi A, Foresti B, Gregoriani R, Ripamonti A, Roveri N (1992) Shah JS The role of magnesium on the structure of biological apatites. Calcif Tissue Int 50:439–44410.1007/BF00296775 ↗
64. Brown KH, Wuehler SE, Peerson JM (2001) The importance of zinc in human nutrition and estimation of the global prevalence of zinc deficiency. Food Nutr Bull 22:113–12510.1177/156482650102200201 ↗
65. Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME (2012) Zinc and human health: an update. Arch Toxicol 86:521–53410.1007/s00204-011-0775-1 ↗
66. Yamaguchi M, Yamaguchi R (1986) Action of zinc on bone metabolism in rats. Increases in alkaline phosphatise activity and DNA content. Biochem Pharmacol 35:773–77710.1016/0006-2952(86)90245-5 ↗
67. Holloway WR, Collier FM, Herbt RE, Hodge JM, Nicolson GC (1996) Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number. Bone 19:137–14210.1016/8756-3282(96)00141-X ↗
68. Lang C, Murgia C, Leong M, Tan LW, Perozzi G, Knight D et al (2007) Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation. Am J Physiol Lung Cell Mol Physiol 292(2):L577–L58410.1152/ajplung.00280.2006 ↗
69. Cousins RJ (1998) A role of zinc in the regulation of gene expression. Proc Nutr Soc 57:307–31110.1079/PNS19980045 ↗
70. Kwun IS, Cho YE, Lomeda RAR, Shin HI, Choi JY, Kang YH et al (2010) Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation. Bone 46(3):732–74110.1016/j.bone.2009.11.003 ↗
71. Brandao NJ, Stefan V, Mendonca BB, Bloise W, Castro AVV (1995) The essential role of zinc in growth. Nutr. Res. 15:335–35810.1016/0271-5317(95)00003-8 ↗
72. Williams C, McBride S, Mostler K, Petrone DM, Simone AJ, Crawford R, Patel S, Petrone ME, Chaknis P, DeVizio W, Volpe AR, Proskin HM (1998) Efficacy of a dentifrice containing zinc citrate for the control of plaque and gingivitis: a 6-month clinical study in adults. Compend Contin Educ Dent 19(2):4–15
73. D’Haese PC, Van Landeghem GF, Lamberts LV, Bekaert VA, Schrooten I, De Broe ME (1997) Measurement of strontium in serum, urine, bone, and soft tissues by Zeeman atomic absorption spectrometry. Clin Chem 43(1):121–12810.1093/clinchem/43.1.121 ↗
74. Dahl SG, Allain P, Marie PJ, Mauras Y, Boivin G, Ammann P, Tsouderos Y, Delmas PD, Christiansen C (2001) Incorporation and distribution of strontium in bone. Bone 28(4):446–45310.1016/S8756-3282(01)00419-7 ↗
75. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350(5):459–46810.1056/NEJMoa022436 ↗
76. Bonnelye E, Chabadel A, Saltel F, Jurdic P (2008) Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 42(1):129–13810.1016/j.bone.2007.08.043 ↗
77. Sila-asna M, Bunyaratvej A (2007) Kobe University Repository: kernel. Kobe J Med Sci 53(1):25–35
78. Marie PJ (2006) Strontium ranelate: a physiological approach for optimizing bone formation and resorption. Bone 38(2):S10–S1410.1016/j.bone.2005.07.029 ↗
79. Brauer DS, Karpukhina N, Kedia G, Bhat A, Law RV, Radecka I, Hill RG (2012) Bactericidal strontium-releasing injectable bone cements based on bioactive glasses. J R Soc Interfac 10(78):1–810.1098/rsif.2012.0647 ↗
80. Saidak Z, Marie PJ (2012) Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis. Pharmacol Ther 136(2):216–22610.1016/j.pharmthera.2012.07.009 ↗
81. Reginster JY (2002) Strontium ranelate in osteoporosis. Curr Pharm Design 8(21):1907–191610.2174/1381612023393639 ↗
82. Peng SL, Zhou GQ, Luk KDK, Cheung KMC, Li ZY, Lam WM, Zhou ZJ, Lu WW (2009) Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Cell Physiol Biochem 23(1–3):165–17410.1159/000204105 ↗
83. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, Vignery A (2001) Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone 29(2):176–17910.1016/S8756-3282(01)00484-7 ↗
84. Dollwet H, Sorenso J (1985) Historic uses of copper compounds in medicine. Trace Elements in Medicine 2(2):80–87
85. Stanic V, Dimitrijevic S, Antic-Stankovic J, Mitric M, Jokic B, Plecas IB, Raicevic S (2010) Synthesis, characterization and antimicrobial activity of copper and zinc-doped hydroxyapatite nanopowders. Appl Surf Sci 256(20):6083–608910.1016/j.apsusc.2010.03.124 ↗
86. Hu GF (1998) Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 69(3):326–33510.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A ↗
87. Rodríguez JP, Ríos S, González M (2002) Modulation of the proliferation and differentiation of human mesenchymal stem cells by copper. J Cell Biochem 85(1):92–10010.1002/jcb.10111 ↗
88. Zhang JC, Huang JA, Xu SJ, Wang K, Yu SF (2003) Effects of Cu2+ and pH on osteoclastic bone resorption in vitro. Prog Nat Sci 13(4):266–270
89. Kothapalli CR, Ramamurthi A (2009) Copper nanoparticle cues for biomimetic cellular assembly of crosslinked elastin fibers. Acta Biomater 5:541–55310.1016/j.actbio.2008.09.004 ↗
90. Finney L, Vogt S, Fukai T, Glesne D (2009) Copper and angiogenesis: unravelling a relationship key to cancer progression. Clin Exp Pharmacol Physiol 36(1):88–9410.1111/j.1440-1681.2008.04969.x ↗
91. Gérard C, Bordeleau L-J, Barralet J, Doillon CJ (2010) The stimulation of angiogenesis and collagen deposition by copper. Biomaterials 31(5):824–83110.1016/j.biomaterials.2009.10.009 ↗
92. Feng W (2009) YeF, Xue W, Zhou Z, Kang YJ. Copper regulation of hypoxia-inducible factor-1 activity. Mol Pharmacol 75:174–18210.1124/mol.108.051516 ↗
93. Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, Hunt TK et al (2002) Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 282:H1821–H182710.1152/ajpheart.01015.2001 ↗
94. Li S, Xie H, Li S, Kang YJ (2012) Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway. Exp Biol Med 237:77–8210.1258/ebm.2011.011267 ↗
95. Gaetke LM, Chow CK (2003) Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 189:147–16310.1016/S0300-483X(03)00159-8 ↗
96. Hung YH, Bush AI, Cherny RA (2010) Copper in the brain and Alzheimer’s disease. J Biol Inorg Chem 15:61–7610.1007/s00775-009-0600-y ↗
97. Bejarano J, Caviedes P, Palza H (2015) Sol–gel synthesis and in vitro bioactivity of copper and zinc-doped silicate bioactive glasses and glass-ceramics. Biomed Mater 10(2):02500110.1088/1748-6041/10/2/025001 ↗
98. Bini M, Grandi S, Capsoni D, Mustarelli P, Saino E, Visai L (2009) SiO2–P2O5–CaO glasses and glass-ceramics with and without ZnO: relationships among composition, microstructure, and bioactivity. J Phys Chem C 113:8821–882810.1021/jp810977w ↗
99. Aina V, Cerrato G, Martra G, Malavasi G, Lusvardi G, Menabue L (2013) Towards the controlled release of metal nanoparticles from biomaterials: physico-chemical, morphological and bioactivity features of Cu-containing sol–gel glasses. Appl Surf Sci 283:240–24810.1016/j.apsusc.2013.06.093 ↗
100. Aina V, Malavasi G, Fiorio Pla A, Munaron L, Morterra C (2009) Zinc-containing bioactive glasses: surface reactivity and behaviour towards endothelial cells. Acta Biomater 5:1211–122210.1016/j.actbio.2008.10.020 ↗